Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$13.58 - $17.36 $48,276 - $61,714
-3,555 Reduced 66.18%
1,817 $29,000
Q4 2023

Feb 06, 2024

SELL
$10.11 - $16.54 $4,741 - $7,757
-469 Reduced 8.03%
5,372 $87,000
Q2 2023

Aug 11, 2023

BUY
$13.28 - $15.96 $3,200 - $3,846
241 Added 4.3%
5,841 $82,000
Q1 2023

May 02, 2023

SELL
$14.26 - $22.1 $10,167 - $15,757
-713 Reduced 11.29%
5,600 $87,000
Q4 2022

Feb 10, 2023

BUY
$14.85 - $19.04 $2,257 - $2,894
152 Added 2.47%
6,313 $103,000
Q3 2022

Nov 09, 2022

BUY
$12.38 - $20.23 $383 - $627
31 Added 0.51%
6,161 $114,000
Q2 2022

Aug 15, 2022

SELL
$9.11 - $13.98 $601 - $922
-66 Reduced 1.07%
6,130 $81,000
Q1 2022

Jun 30, 2022

SELL
$6.87 - $11.11 $3,936 - $6,366
-573 Reduced 8.47%
6,196 $57,000
Q3 2021

Oct 29, 2021

SELL
$26.46 - $37.15 $10,610 - $14,897
-401 Reduced 5.59%
6,769 $230,000
Q2 2021

Aug 16, 2021

BUY
$32.73 - $47.95 $55,346 - $81,083
1,691 Added 30.86%
7,170 $262,000
Q1 2021

May 13, 2021

SELL
$40.39 - $56.73 $19,266 - $27,060
-477 Reduced 8.01%
5,479 $246,000
Q4 2020

Feb 12, 2021

BUY
$51.77 - $66.18 $7,092 - $9,066
137 Added 2.35%
5,956 $339,000
Q3 2020

Oct 30, 2020

SELL
$43.8 - $58.16 $7,314 - $9,712
-167 Reduced 2.79%
5,819 $299,000
Q2 2020

Aug 10, 2020

BUY
$37.05 - $65.03 $221,781 - $389,269
5,986 New
5,986 $357,000
Q1 2020

May 13, 2020

SELL
$33.63 - $69.4 $123,993 - $255,877
-3,687 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$31.7 - $69.93 $116,877 - $257,831
3,687 New
3,687 $229,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.